WITHDRAWN: Discovery of mcr-1 Harboring Incl2 Plasmids from Clinical Isolates of Multiclonal E. Coli prevalent in Pakistan.

Hazrat Bilal,Tayyab ur Rehman,Muhammad Asif Khan,Fareeha Hameed,Zhang gao Jian,Jianxiong Han,Xingyuan Yang
DOI: https://doi.org/10.21203/rs.3.rs-74913/v1
2020-01-01
Abstract:Abstract Background: Colistin is the last resort antibiotic against multiple drug-resistant (MDR) bacteria found in clinical infections; however, the emergence of plasmid-mediated mcr-1 gene annulled the efficacy of Colistin. This study was planned to determine the prevalence of mcr genes in clinical isolates collected in Pakistan. The molecular types and plasmids of mcr-1 bearing isolates were analysed. Methods: A total of 545 E. coli isolates collected from two major cities of Pakistan were screened for colistin-resistance and mcr genes from June 2018 to September 2019. All positive strains were subjected to antimicrobial susceptibility testing, ESBL, and MBL detection via DDST and CDT. ESBL genes detection, molecular typing, conjugation experiment, plasmid replicon typing, S1 PFGE, and southern hybridization were performed. Results: Four (0.73%) strains of mcr-1 positive isolates were susceptible to meropenem, fosfomycin, and chloramphenicol, including one that showed moderate level resistance to chloramphenicol and fosfomycin. All four strains were ESBL positive and harbored the blaCTX-M-15 gene, while three of the isolates also harbored the blaTEM-1 gene. Molecular typing revealed that four isolates belonged to diverse clonal types, mostly (75%) from avian pathogenic E. coli lineage. The mcr-1 gene was present on ~ 60 kb Incl2 plasmid, which was successfully transconjugated. Conclusion: The mcr-1 gene's detection in diverse clonal types from MDR clinical isolates enforces priority basis large scale surveillance studies followed by corrective actions to prevent the spread of the mcr-1 gene in clinical, poultry, and environmental setting.
What problem does this paper attempt to address?